Project Details
Description
NOVEL DRUG/RECEPTOR CODELIVERY TO THE LIVER-LUNG AXIS TO OVERCOME GLUCOCORTICOID RESISTANCE AND ACUTE RESPIRATORY DISTRESS SYNDROME IN SEPSIS
| Status | Finished |
|---|---|
| Effective start/end date | 05/1/23 → 04/30/26 |
Funding
- US Army Medical Research Acquisition Activity: $325,984.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.